{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T05:43:55Z","timestamp":1671255835900},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,1]]},"DOI":"10.1093\/jac\/dkx512","type":"journal-article","created":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T07:10:31Z","timestamp":1516086631000},"page":"829-830","source":"Crossref","is-referenced-by-count":1,"title":["High levels of susceptibility to new and older antibiotics in Neisseria gonorrhoeae isolates from Saskatchewan (2003\u201315): time to consider point-of-care or molecular testing for precision treatment?\u2014authors\u2019 response"],"prefix":"10.1093","volume":"73","author":[{"given":"Sidharath D","family":"Thakur","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada"},{"name":"Vaccine and Infectious Disease Organization - International Vaccine Centre (VIDO-InterVac), University of Saskatchewan, Saskatoon, Saskatchewan, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo-Anne R","family":"Dillon","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada"},{"name":"Vaccine and Infectious Disease Organization - International Vaccine Centre (VIDO-InterVac), University of Saskatchewan, Saskatoon, Saskatchewan, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,1,18]]},"reference":[{"key":"key\n\t\t\t\t20180216030028_dkx512-B1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/jac\/dkx333","article-title":"High levels of susceptibility to new and older antibiotics in Neisseria gonorrhoeae isolates from Saskatchewan (2003\u201315): time to consider point-of-care or molecular testing for precision treatment?","volume":"73","author":"Thakur","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180216030028_dkx512-B2","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/jac\/dkx408","article-title":"Comment on: High levels of susceptibility to new and older antibiotics in Neisseria gonorrhoeae isolates from Saskatchewan (2003\u201315): time to consider point-of-care or molecular testing for precision treatment?","volume":"73","author":"Davido","year":"2018","journal-title":"J Antimicrobial Chemother"},{"key":"key\n\t\t\t\t20180216030028_dkx512-B3","first-page":"13","article-title":"Single dose aztreonam in treating gonorrhoea","volume":"63","author":"Tait","year":"1987","journal-title":"Genitourin Med"},{"key":"key\n\t\t\t\t20180216030028_dkx512-B4","doi-asserted-by":"crossref","first-page":"612.","DOI":"10.1093\/infdis\/148.3.612","article-title":"Effectiveness of aztreonam, a new monobactam antibiotic, against penicillin-resistant gonococci","volume":"148","author":"Miller","year":"1983","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180216030028_dkx512-B5","first-page":"271","article-title":"Aztreonam, a new approach in the therapy of gonorrhea","volume":"103","author":"St\u00f6berl","year":"1991","journal-title":"Wien Klin Wochenschr"},{"key":"key\n\t\t\t\t20180216030028_dkx512-B6","first-page":"3","volume-title":"Aztreonam: The Antibiotic Discovery for Gram-Negative Infections","author":"Sykes","year":"1985"},{"key":"key\n\t\t\t\t20180216030028_dkx512-B7","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1128\/AAC.36.8.1682","article-title":"Antibiotic susceptibility survey of Neisseria gonorrhoeae in Thailand","volume":"36","author":"Clendennen","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180216030028_dkx512-B8","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1128\/AAC.45.12.3603-3606.2001","article-title":"Outbreak of cefozopran (penicillin, oral cephems, and aztreonam)-resistant Neisseria gonorrhoeae in Japan","volume":"45","author":"Muratani","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180216030028_dkx512-B9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s101560170034","article-title":"Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce \u03b2-lactamase","volume":"7","author":"Akasaka","year":"2001","journal-title":"J Infect Chemother"},{"key":"key\n\t\t\t\t20180216030028_dkx512-B10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1185\/03007998509109639","article-title":"The use of aztreonam in the treatment of uncomplicated gonorrhoea","volume":"9","author":"Spencer","year":"1985","journal-title":"Curr Med Res Opin"},{"key":"key\n\t\t\t\t20180216030028_dkx512-B11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1128\/AAC.27.2.270","article-title":"Effectiveness of aztreonam for the treatment of gonorrhea","volume":"27","author":"Gottlieb","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180216030028_dkx512-B12","first-page":"318","article-title":"Treatment of uncomplicated gonorrhoea with single dose aztreonam","volume":"62","author":"Evans","year":"1986","journal-title":"Genitourin Med"},{"key":"key\n\t\t\t\t20180216030028_dkx512-B13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jiac.2015.10.002","article-title":"In vitro potency and combination testing of antimicrobial agents against Neisseria gonorrhoeae","volume":"22","author":"Bharat","year":"2016","journal-title":"J Infect Chemother"},{"key":"key\n\t\t\t\t20180216030028_dkx512-B14","first-page":"1466","article-title":"Repurposing an old drug: aztreonam as a new treatment strategy for gonorrhoea","volume":"72","author":"Davido","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180216030028_dkx512-B15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2165\/00003495-199039040-00004","article-title":"Optimum therapy for acute pelvic inflammatory disease","volume":"39","author":"Dodson","year":"1990","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20180216030028_dkx512-B16","volume-title":"Canadian Guidelines on Sexually Transmitted Infections. Section 4. Management and Treatment of Specific Syndromes. Pelvic Inflammatory Disease","author":"Public Health Agency of Canada","year":"2013"},{"key":"key\n\t\t\t\t20180216030028_dkx512-B17","first-page":"1","article-title":"Antibiotic resistance in Neisseria gonorrhoeae isolates: will infections be untreatable in the future?","volume":"35","author":"Dillon","year":"2015","journal-title":"Culture (Oxoid)"},{"key":"key\n\t\t\t\t20180216030028_dkx512-B18","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMc1512757","article-title":"Failure of dual antimicrobial therapy in treatment of gonorrhea","volume":"374","author":"Fifer","year":"2016","journal-title":"N Engl J Med"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/3\/829\/23823787\/dkx512.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T03:00:35Z","timestamp":1518750035000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/3\/829\/4817295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,18]]},"references-count":18,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,1,18]]},"published-print":{"date-parts":[[2018,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx512","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,3]]},"published":{"date-parts":[[2018,1,18]]}}}